SIGN-UP

Participate in 

Research

Our team of professionals are trained to conduct clinical trials for people who want to quit smoking.

Our trials test medications, behavioral approaches and various combinations of both in an attempt to find the most effective smoking cessation treatment. Our staff is also trained to conduct behavioral counseling.


AUS FAQ

1What are the criteria to participate?
  • Between 22-65 years old
  • Not pregnant, nursing, or planning to become pregnant
  • Has a smartphone with iOS 12.4+ or Android 12+
  • Currently smokes cigarettes daily
  • No current serious medical conditions
  • No known allergies or sensitivities to any ingredients found in e-cigarette products or any of the components in e-liquids (nicotine, flavor, benzoic acid, propylene glycol and glycerol, menthol, peppermint oil)​
  • Lives within driving distance of our offices in Raleigh, or Charlotte, NC
2How long is the study?
Your participation in this study will last about four weeks and will include 3 visits to the study center. This first visit will include screening procedures and will take about 1-2 hours. The other study visits will last about 30-45 minutes.
3Will I be compensated for my participation in this study?
The maximum compensation you may receive without unscheduled visits is $470. You will be compensated for your time and inconvenience related to your participation in this study. If you do not complete the study, for any reason, you will be paid for the study visits and tasks you do complete according to the following schedule:
  • You will receive $50 for completing screening procedures at your first visit.
  • During the four-week product use period you will receive $50 for completing each weekly survey within three days (total $200).
  • You will receive a payment of $50 for attending study visit 2 and $70 for attending study visit 3 (total $120).
  • If you complete the entire study and return all study products you will receive an additional payment of $100.
  • You will receive compensation via the Greenphire ClinCard, a prepaid MasterCard debit card. Greenphire will collect your name, address, date of birth, and social security number to activate your debit card. The visit amount will be loaded onto the card within 48 hours of completing that visit. Payment received as compensation for participation in this study is considered taxable income. You are responsible for paying any state, federal or Social Security taxes on the money you receive. If your total payment exceeds $600 in any one calendar year, we are required to report this information to the Internal Revenue Service (IRS). You will be required to provide your Social Security number or tax identification number for payment. If participants are asked by study staff to return to the center to complete or redo parts of a visit due to equipment malfunctions or other circumstances that are beyond their control, they may be reimbursed for mileage. Participants who decide to withdraw from the study will be paid for the part of the study they have completed.
    4Who is funding the study?
    The study is being funded by Juul Labs, Inc.

    The AUS Study

    The main purpose of this Study is to better understand how adult smokers use the Study Product and how they feel about it. The Study Product has been developed by Juul Labs, Inc. (“the Sponsor”), to provide adult smokers with an alternative to cigarette smoking. 

    SIGN-UP

    For Future 

    Studies

    Fill out our form below for more information

    Participant information is maintained in a volunteer database system and retained for future studies as they become available. Pertinent information is confidentially kept on file to aid in selecting highly qualified candidates for research studies.


    Volunteer Profile - Full PreScreen

    Why should I participate?

    Participants may gain access to new research treatments before they are widely available.

    Additionally, participants are compensated for their time and receive study-related products and medications at no cost. You may be among the first to benefit if the approach being studied is found to be helpful.